deltatrials
Terminated PHASE2 INTERVENTIONAL 3-arm NCT03436433

Seizure Prophylaxis in Patients With Glioma or Brain Metastasis

Phase II Trial of Seizure Prophylaxis in Brain Tumor Patients Undergoing Neurosurgical Procedure

Sponsor: Duke University

Conditions Brain Tumor Glioma Glioma of Brain
Interventions Lacosamide Levetiracetam
Updated 15 times since 2018 Last updated: Apr 11, 2023 Started: Jan 31, 2019 Primary completion: Dec 4, 2020 Completion: Dec 4, 2020
This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Terminated

Did not enroll as planned

Other terminated trials from Duke University

See all terminations from Duke University

Other Brain Tumor trials with similar outcome

Browse all Brain Tumor trials

Listed as NCT03436433, this PHASE2 trial focuses on Brain Tumor and Glioma and remains terminated or withdrawn. Sponsored by Duke University, it has been updated 15 times since 2019, reflecting substantial change activity. This study contributes to the evolving evidence base for cancer treatment protocols.

Status Flow

~Mar 2018 – ~Jun 2018 · 3 months · monthly snapshot~Jun 2018 – ~Jul 2018 · 30 days · monthly snapshot~Jul 2018 – ~Aug 2018 · 31 days · monthly snapshot~Aug 2018 – ~Dec 2018 · 4 months · monthly snapshot~Dec 2018 – ~Mar 2019 · 3 months · monthly snapshot~Mar 2019 – ~Oct 2019 · 7 months · monthly snapshot~Oct 2019 – ~May 2020 · 7 months · monthly snapshot~May 2020 – ~Oct 2020 · 5 months · monthly snapshot~Oct 2020 – ~Jan 2021 · 3 months · monthly snapshot~Jan 2021 – ~Apr 2021 · 3 months · monthly snapshot~Apr 2021 – ~Jan 2022 · 9 months · monthly snapshot~Jan 2022 – ~May 2023 · 16 months · monthly snapshot~May 2023 – ~Jul 2024 · 14 months · monthly snapshot~Jul 2024 – ~Sep 2024 · 2 months · monthly snapshot~Sep 2024 – present · 22 months · monthly snapshot

Change History

15 versions recorded

  1. Sep 2024 — Present [monthly]

    Terminated PHASE2

  2. Jul 2024 — Sep 2024 [monthly]

    Terminated PHASE2

  3. May 2023 — Jul 2024 [monthly]

    Terminated PHASE2

  4. Jan 2022 — May 2023 [monthly]

    Terminated PHASE2

  5. Apr 2021 — Jan 2022 [monthly]

    Terminated PHASE2

    Status: Recruiting → Terminated

▶ Show 10 earlier versions

  1. Jan 2021 — Apr 2021 [monthly]

    Recruiting PHASE2

  2. Oct 2020 — Jan 2021 [monthly]

    Recruiting PHASE2

    Status: Suspended → Recruiting

  3. May 2020 — Oct 2020 [monthly]

    Suspended PHASE2

    Status: Recruiting → Suspended

  4. Oct 2019 — May 2020 [monthly]

    Recruiting PHASE2

  5. Mar 2019 — Oct 2019 [monthly]

    Recruiting PHASE2

    Status: Not Yet Recruiting → Recruiting

  6. Dec 2018 — Mar 2019 [monthly]

    Not Yet Recruiting PHASE2

  7. Aug 2018 — Dec 2018 [monthly]

    Not Yet Recruiting PHASE2

  8. Jul 2018 — Aug 2018 [monthly]

    Not Yet Recruiting PHASE2

  9. Jun 2018 — Jul 2018 [monthly]

    Not Yet Recruiting PHASE2

  10. Mar 2018 — Jun 2018 [monthly]

    Not Yet Recruiting PHASE2

    First recorded

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:
  • Duke University
Data source: Duke University

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations